Controlled release of celecoxib inhibits inflammation, bone cysts and osteophyte formation in a preclinical model of osteoarthritis.

Drug Deliv · 2018 · PMC6058666 · PMID 29890922

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

borderline significantp = .058so close (0.05 < p ≤ 0.1)

One week after IA injection of (un)loaded-PEAMs and throughout the whole study period, only borderline significant differences compared to pretreatment values were found ( p = .058).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.